Dublin, May 30, 2017 -- Research and Markets has announced the addition of the "Global Semen Analysis Market Outlook: 2017-2022" report to their offering.
The global semen analysis market will increase at a CAGR of 8.9% from 2017 to 2022 to USD 355.6 million by 2022, driven by lifestyle change, growing disposable income in the developing countries, increasing animal health expenditure, growing animal population, and rising demand for animal derived food products, and increase in fertility tourism. However, high cost of assisted reproductive technology and imposition of medical device excise tax in the U.S. are expected to hinder the growth of the market to some extent.
Semen analysis is done to evaluate male fertility, for those seeking pregnancy or verifying the success of vasectomy as well as for veterinary applications such as artificial insemination and animal breeding. The analysis is conducted to evaluate descriptive parameters of the sperm including its volume, concentration, motility, viability, and normal morphology based on various guidelines. Infertility has been a major cause contributing to the growth of semen analysis market, cited to the abnormal sperm functioning, problem with sperm delivery, overexposure to certain environmental factors such as pesticides and other chemicals and radiation, cigarette smoking, and heavy alcohol consumption.
The global semen analysis market is fragmented with the presence of many local and regional players. The leading companies have employed various strategies to expand their product and services offerings, global footprint, and augment their market share. The key strategy followed by most companies in the global semen analysis market was new product launches/ developments, during the period of 2014-2017, enabling companies to expand their product offerings and ensure a competitive edge in the global semen analysis market.
Key questions answered in the report:
- Which are the high growth market segments in terms of semen analysis products, applications, and geographies?
- What is the historical market for semen analysis across the globe?
- What are the semen analysis market forecasts and estimates from the period 2015-2022?
- What are the major drivers, restrains, and opportunities in the global semen analysis market?
- Who are the major players in the global semen analysis market and what percentage of share do they hold in global semen analysis market?
- What are the recent developments in the global semen analysis market?
- What are the geographical trends related to semen analysis market and high growth regions/ countries?
- What are the local emerging players in the semen analysis market and how do they compete with the global players?
Key Topics Covered:
1 Introduction
1.1 Market Ecosystem
1.2 Report Elucidation
1.3 Market buzz and foreground
1.4 Research Methodology
1.4.1 Primary
1.4.2. Secondary
1.4.3 Market Analytics
2 Executive Summary
3 Market Insights
4 Global Semen Analysis Market, By Application
4.1 Human
4.2 Veterinary
4.2.1 Equine
4.2.2 Porcine
4.2.3 Bovine
4.2.4 Turkey
5 Global Semen Analysis Market, By Products
5.1 Analyzers
5.2 Accessories and Disposables
5.3 Software
5.4 Instruments
5.4.1 Centrifuge
5.4.2 Counting Chambers
5.4.3 Temperature Control System
5.5 Test Kit
6 Semen Analysis Market, By Geography
7 Global Semen Analysis Market- Competitive Landscape
7.1 Introduction
7.2 New Product Launches
7.3 Agreements, Partnerships & Collaboration
7.4 Expansions
7.5 Mergers & Acquisitions
7.6 Other Developments
8 Company Profiles (The Profile Includes Company Overview, Financials, Products and Services Portfolio, and Recent Developments)
8.1 Bioline Technologies
8.2 Biophos
8.3 ContraVac INC
8.4 Dolo Animals Ltd.
8.5 Hamilton Thorne
8.6 LabIVF Asia PTE. LTD.
8.7 Medical Electronics System LTD.
8.8 MedSystems International LLC
8.9 Microptic S.L.
8.10 MMCSoft
8.11 MotilityCount Aps
8.12 Origio
8.13 Proiser
8.14 Sperm Processor Pvt. Ltd.
8.15 Stormoff
For more information about this report visit http://www.researchandmarkets.com/research/4zngmw/global_semen
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Healthcare Services


China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
Want to cut your energy bills? Here’s how five experts are doing it
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
John Ternus Signals Apple’s Future with Product-First AI Strategy
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 



